EVMN News
Official issuer or fund updates, exact SEC current reports, and large established publisher coverage, newest first. Every lawfully retained item remains in the corpus; each public page contains at most 100 rows. Headlines open the exact source; summaries are concise descriptions and not investment recommendations. Captured 2026-08-31.
| Date | Type | Publisher | Headline | Summary |
|---|---|---|---|---|
| 2026-08-06 | Current report | SEC filing | Evommune, Inc. filed Form 8-K | Evommune, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2026-07-30 | Current report | SEC filing | Evommune, Inc. filed Form 8-K | Evommune, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2026-06-29 | Current report | SEC filing | Evommune, Inc. filed Form 8-K | Evommune, Inc. filed Form 8-K covering items 7.01,8.01,9.01. |
| 2026-06-02 | Current report | SEC filing | Evommune, Inc. filed Form 8-K | Evommune, Inc. filed Form 8-K covering items 5.07. |
| 2026-05-07 | Current report | SEC filing | Evommune, Inc. filed Form 8-K | Evommune, Inc. filed Form 8-K covering items 2.02,7.01. |
| 2026-04-13 | Current report | SEC filing | Evommune, Inc. filed Form 8-K | Evommune, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2026-03-05 | Current report | SEC filing | Evommune, Inc. filed Form 8-K | Evommune, Inc. filed Form 8-K covering items 2.02. |
| 2026-02-13 | Current report | SEC filing | Evommune, Inc. filed Form 8-K | Evommune, Inc. filed Form 8-K covering items 1.01,3.02,7.01,9.01. |
| 2026-02-10 | Current report | SEC filing | Evommune, Inc. filed Form 8-K | Evommune, Inc. filed Form 8-K covering items 7.01,9.01. |
| 2025-12-11 | Current report | SEC filing | Evommune, Inc. filed Form 8-K | Evommune, Inc. filed Form 8-K covering items 2.02,9.01. |
| 2025-11-07 | Current report | SEC filing | Evommune, Inc. filed Form 8-K | Evommune, Inc. filed Form 8-K covering items 5.03,9.01. |